首页 | 本学科首页   官方微博 | 高级检索  
检索        


A Prospective, Double-Blind, Multicenter, Randomized Trial Comparing Ertapenem 3 Vs ≥5 Days in Community-Acquired Intraabdominal Infection
Authors:Antonio Basoli  Piero Chirletti  Ercole Cirino  Nicola G D’Ovidio  Giovanni Battista Doglietto  Domenico Giglio  Stefano M Giulini  Alberto Malizia  Mario Taffurelli  Jelena Petrovic  Maurizio Ecari
Institution:(1) Department “Paride Stefanini”, University “La Sapienza”, Policlinico Umberto I. Viale del Policlinico, 00161 Rome, Italy;(2) Department of Emergency Surgery, University “ La Sapienza”, Rome, Italy;(3) Department of Emergency Surgery, University of Catania, Catania, Italy;(4) Department of Emergency Surgery, University of Sassari, Sassari, Italy;(5) Department of Surgery, Catholic University of Rome, Rome, Italy;(6) Department of Surgery, S. Giovanni Bosco Hospital, Naples, Italy;(7) Department of Surgery, University of Brescia, Brescia, Italy;(8) Department of Emergency Surgery, University of Bologna, Bologna, Italy;(9) Merck Sharp and Dohme, Rome, Italy
Abstract:Severe secondary peritonitis is diagnosed in only 20–30% of all patients, but studies to date have persisted in using a standard fixed duration of antibiotic therapy. This prospective, double-blind, multicenter, randomized clinical study compared the clinical and bacteriological efficacy and tolerability of ertapenem (1 g/day) 3 days (group I) vs ≥5 days (group II) in 111 patients with localized peritonitis (appendicitis vs non-appendicitis) of mild to moderate severity, requiring surgical intervention. In evaluable patients, the clinical response as primary efficacy outcome were assessed at the test-of-cure 2 and 4 weeks after discontinuation of antibacterial therapy. Ninety patients were evaluable. In groups I and II, 92.9 and 89.6% of patients were cured, respectively; 95.3% in group I and 93.7% in group II showed eradication. These differences were not statistically significant. The most frequent bacteria recovered were Escherichia coli and Bacteroides fragilis. A wound infection developed in seven patients (7.7%) and an intraabdominal infection in one patient (1.1%). There was a low frequency of drug-related clinical or laboratory adverse effects in both groups. Our study demonstrated that, in patients with localized community-acquired intraabdominal infection, a 3-day course of ertapenem had the same clinical and bacteriological efficacy as a standard duration. Italian study group: Paolo Mazzocchi, Luigi Solinas, and Fulvio D’Ostuni, Department “Paride Stefanini”, University “La Sapienza”, Rome, Italy; Roberto Caronna, Department of Emergency Surgery, University “ La Sapienza”, Rome, Italy; Antonino Buffone, Department of Emergency Surgery, University of Catania, Catania, Italy; Teresa Verde and Claudia Massaiu, Department of Emergency Surgery, University of Sassari, Sassari, Italy; Dario Di Miceli, Department of Surgery, Catholic University of Rome, Rome, Italy; Salvatore Di Muria, Department of Surgery, S. Giovanni Bosco Hospital, Naples, Italy; Edoardo Cervi, Department of Surgery, University of Brescia, Brescia, Italy; Fausto Catena, Department of Emergency Surgery, University of Bologna, Bologna, Italy; Massimo Coletti and Stefano Scozzafava, Department of Emergency Surgery, University “La Sapienza”, Rome, Italy This paper was presented at the 20th meeting of the International Society for Digestive Surgery, Rome, Italy, November 29–December1, 2006.
Keywords:Peritonitis  Ertapenem  Localized intraabdominal infection  Surgical and antibiotic therapy
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号